PHARMALINE
The computed 12-month bankruptcy probability of PHARMALINE is 0.8% (low). The 2024 annual accounts show equity of €6k and a net result of €60k. Equity is shrinking by ~411.5% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2025. Its solvency ranks better than 24% of 858 sector peers (fiscal year 2024). The company has been active since 1986 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €6k |
| Net result | €60k |
| Staff (FTE) | 2.1 |
| Better than sector | 24% |
Strong profile, led by profitability.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 1.2% | 17.5% | |
| Net result | €60k | €14k | |
| Equity | €6k | €101k | |
| Gross operating margin | €199k | €213k | |
| Staff costs | €116k | €219k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €82k |
| Net profit | €60k |
| Cash flow | €62k |
| Staff costs | €116k |
| Income taxes | €21k |
| Dividends | €62k |
| Total assets | €524k |
| Equity | €6k |
| Debt | €518k |
| of which ≤ 1y | €518k |
| of which > 1y | - |
| Working capital | €-4k |
| Employees (FTE) | 2.1 |
| 2024 | |
|---|---|
| Current ratio | 0.99 |
| Quick ratio | 0.81 |
| Working capital ratio | -0.8% |
| Solvency | 1.2% |
| Debt / equity | 81.07 |
| Long-term debt ratio | - |
| Interest coverage | 267.10 |
| Gross margin | - |
| Net margin | - |
| ROA | 11.4% |
| ROE | 938.8% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €524k |
| Fixed assets | 21/28 | €10k |
| Formation expenses | 20 | €938 |
| Tangible fixed assets | 22/27 | €10k |
| Financial fixed assets | 28 | €100 |
| Current assets | 29/58 | €514k |
| Stocks & contracts in progress | 3 | €95k |
| Amounts receivable within one year | 40/41 | €138k |
| Cash & bank | 54/58 | €276k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €524k |
| Equity | 10/15 | €6k |
| Contributions / capital | 10/11 | €6k |
| Amounts payable | 17/49 | €518k |
| Amounts payable within one year | 42/48 | €518k |
| Trade debts payable within one year | 44 | €150k |
| Income statement | ||
| Gross operating margin | 9900 | €199k |
| Operating result | 9901 | €80k |
| Financial income | 75 | €1k |
| Financial charges | 65 | €308 |
| Result before taxes | 9903 | €81k |
| Income taxes | 67/77 | €21k |
| Net result for the period | 9904 | €60k |
| Result to be appropriated | 9905 | €60k |
| NACE primary | Retail trade(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 25-03-1986 |
| Status | Active |
| Postal code | 6183 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52066B0734/00K000 | Wallonia | 799 m² | 2 · 146 m² | 11.4 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
06-12-2023 Board composition published
Technical details
{
"events": [
{
"kind": "substantive_delegation",
"role": "directeur",
"person": {
"rrn": null,
"name": "Fran\u00E7ois STEEMAN",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "board_snapshot",
"role": null,
"person": null,
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Alexandre PICART",
"firm_city": null,
"firm_name": null,
"office_city": "Courcelles",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2023-12-06",
"filing_date": "2023-12-03",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2023-11-30",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0428.751.579",
"name_full": "PHARMALINE",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Alexandre Picart",
"org_rep_person_name": null,
"person_role_at_subject": "notaire"
},
"co_filed_documents": [
"Exp\u00E9dition de l\u2019acte",
"Statuts coordonn\u00E9s"
],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | PHARMALINE |
| AbbreviationFR | PHARMAKO |